204 related articles for article (PubMed ID: 12486568)
1. [Treatment of hip adductor spasticity with botulinum toxin type B].
Oechsner M
Nervenarzt; 2002 Dec; 73(12):1179-82. PubMed ID: 12486568
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
4. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
6. [Local injection treatment with botulinum toxin A in severe arm and leg spasticity].
Konstanzer A; Ceballos-Baumann AO; Dressnandt J; Conrad B
Nervenarzt; 1993 Aug; 64(8):517-23. PubMed ID: 8413750
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in treating spasticity.
Das TK; Park DM
Br J Clin Pract; 1989 Nov; 43(11):401-3. PubMed ID: 2611094
[TBL] [Abstract][Full Text] [Related]
8. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spasticity with botulinum toxin: a double-blind study.
Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
[TBL] [Abstract][Full Text] [Related]
10. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
Calne S
Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
13. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
Phadke CP; Davidson C; Ismail F; Boulias C
PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
[TBL] [Abstract][Full Text] [Related]
14. Botulinum treatment for post-stroke spasticity: low dose regime.
Viriyavejakul A; Vachalathiti R; Poungvarin N
J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
[TBL] [Abstract][Full Text] [Related]
15. Preoperative treatment with Botulinum Toxin A before total hip arthroplasty in a patient with tetraspasticity: Case report and review of literature.
Eibach S; Krug H; Lobsien E; Hoffmann KT; Kupsch A
NeuroRehabilitation; 2011; 28(2):81-3. PubMed ID: 21447907
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of spasticity with botulinum toxin].
Mémin B; Pollak P; Hommel M; Perret J
Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
19. [Experiences with botulinum toxin injections against spasticity in children].
Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
[TBL] [Abstract][Full Text] [Related]
20. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
